Overview
Haruhiko Midorikawa practices practicing medicine in Tsukuba, Japan.
Their clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), Telangiectasia, and Calcinosis.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haruhiko Midorikawa
Is Haruhiko Midorikawa a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Haruhiko Midorikawa is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haruhiko Midorikawa participate in research or clinical trials?
Yes. Haruhiko Midorikawa has published 21 articles and abstracts on conditions like COVID-19. You can view a list of Haruhiko Midorikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CalcinosisMidorikawa isExperienced. Learn about Calcinosis.
- COVID-19Midorikawa isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)
- TelangiectasiaMidorikawa isExperienced. Learn about Telangiectasia.